Entero Healthcare Solutions Limited (NSE:ENTERO)
India · Delayed Price · Currency is INR 1,408.40
+21.60 (1.56%)
Aug 20, 2026, 3:29 PM IST
NSE:ENTERO Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 71,279 | 65,912 | 50,958 | 39,223 | 33,002 | 25,221 | |
Revenue Growth | 31.94% | 29.35% | 29.92% | 18.85% | 30.85% | 42.24% |
Cost of Revenue | 63,710 | 59,162 | 46,144 | 35,744 | 30,348 | 23,143 |
Gross Profit | 7,568 | 6,751 | 4,814 | 3,480 | 2,654 | 2,077 |
Selling, General & Admin | 2,702 | 2,584 | 2,094 | 1,563 | 1,364 | 1,234 |
Other Operating Expenses | 1,742 | 1,512 | 994.87 | 798.01 | 650.33 | 599.12 |
Operating Expenses | 4,912 | 4,529 | 3,407 | 2,611 | 2,257 | 2,030 |
Operating Income | 2,657 | 2,222 | 1,407 | 868.26 | 397.7 | 46.84 |
Interest Expense | -589.75 | -490.67 | -375.35 | -604.82 | -444 | -260.95 |
Interest & Investment Income | 134.64 | 134.64 | 375.73 | 133.32 | 40.9 | 34.39 |
Currency Exchange Gain (Loss) | 1.93 | 1.93 | - | 0.34 | 0.15 | 1.58 |
Other Non Operating Income (Expenses) | -69.38 | -41.2 | -36.4 | -41.91 | -31.63 | -19.97 |
EBT Excluding Unusual Items | 2,134 | 1,826 | 1,371 | 355.19 | -36.88 | -198.11 |
Gain (Loss) on Sale of Investments | 39.3 | 39.3 | 9.6 | - | - | - |
Gain (Loss) on Sale of Assets | 3.44 | 3.44 | 1.92 | 0.36 | - | - |
Other Unusual Items | -75.82 | -75.82 | 4.87 | - | - | - |
Pretax Income | 2,101 | 1,793 | 1,387 | 355.55 | -36.88 | -198.11 |
Income Tax Expense | 424.34 | 334.96 | 313.05 | -42.44 | 74.16 | 96.28 |
Earnings From Continuing Operations | 1,677 | 1,458 | 1,074 | 397.99 | -111.04 | -294.39 |
Minority Interest in Earnings | -422.54 | -307.98 | -126.14 | -6.9 | -4.53 | -4.81 |
Net Income | 1,254 | 1,150 | 948.2 | 391.09 | -115.57 | -299.2 |
Net Income to Common | 1,254 | 1,150 | 948.2 | 391.09 | -115.57 | -299.2 |
Net Income Growth | 22.30% | 21.33% | 142.45% | - | - | - |
Shares Outstanding (Basic) | 44 | 44 | 43 | 36 | 4 | 2 |
Shares Outstanding (Diluted) | 44 | 44 | 44 | 36 | 4 | 2 |
Shares Change | -0.08% | 0.00% | 20.45% | 779.74% | 163.71% | 1455.99% |
EPS (Basic) | 28.82 | 26.44 | 21.80 | 10.81 | -28.11 | -191.91 |
EPS (Diluted) | 28.78 | 26.40 | 21.76 | 10.81 | -28.11 | -191.91 |
EPS Growth | 22.38% | 21.32% | 101.30% | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 286.6 | -881.8 | -420.28 | -508.34 | -451.31 |
Free Cash Flow Per Share | - | 6.58 | -20.24 | -11.62 | -123.64 | -289.47 |
Gross Margin | 10.62% | 10.24% | 9.45% | 8.87% | 8.04% | 8.24% |
Operating Margin | 3.73% | 3.37% | 2.76% | 2.21% | 1.21% | 0.19% |
Profit Margin | 1.76% | 1.75% | 1.86% | 1.00% | -0.35% | -1.19% |
Free Cash Flow Margin | - | 0.43% | -1.73% | -1.07% | -1.54% | -1.79% |
EBITDA | 2,810 | 2,364 | 1,503 | 950.02 | 487.22 | 118.84 |
EBITDA Margin | 3.94% | 3.59% | 2.95% | 2.42% | 1.48% | 0.47% |
D&A For EBITDA | 153.83 | 142.29 | 96.13 | 81.76 | 89.52 | 72 |
EBIT | 2,657 | 2,222 | 1,407 | 868.26 | 397.7 | 46.84 |
EBIT Margin | 3.73% | 3.37% | 2.76% | 2.21% | 1.21% | 0.19% |
Effective Tax Rate | 20.20% | 18.68% | 22.56% | - | - | - |
Revenue as Reported | 71,443 | 66,104 | 51,353 | 39,367 | 33,057 | 25,265 |
Advertising Expenses | - | 121.11 | 90.42 | 44.88 | 65.88 | 70.98 |